GlassScriptPhysician profile
Troy Weirick
NPI 1679717771
$15,808.01
in general payments reported to CMS, 2019-2025
52 companies · $1,765 in 2025
The $1,765 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,676 · 2020: $1,520 · 2021: $2,198 · 2022: $2,983 · 2023: $2,184 · 2024: $2,482 · 2025: $1,765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,430.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,758.35 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,275.87 | 2019-2024 | Xarelto |
| Medtronic, INC. | $1,135.23 | 2021-2025 | Corevalve Evolut R, Intellis Adaptivestim |
| Edwards Lifesciences Corporation | $1,080.40 | 2019-2025 | Sapien 3 Ultra Resilia |
| Abiomed | $1,069.26 | 2019-2025 | Impella |
| Amgen INC. | $782.66 | 2019-2024 | Repatha |
| Merck Sharp & Dohme LLC | $656.78 | 2021-2025 | Verquvo, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $559.60 | 2019-2025 | Lifevest |
| Shockwave Medical, INC | $558.80 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $556.38 | 2019-2023 | Brilinta, Farxiga |
| Pfizer INC. | $532.15 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $513.58 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $509.85 | 2019-2025 | Camzyos, Eliquis |
| Penumbra, INC. | $430.68 | 2019-2024 | Penumbra System, Smart Coil, Indigo System |
| Esperion Therapeutics, INC. | $419.57 | 2020-2025 | Nexletol |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $404.13 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Amulet |
| Bayer Healthcare Pharmaceuticals INC. | $359.68 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $274.47 | 2019-2024 | |
| Chiesi USA, INC. | $273.76 | 2020-2024 | Kengreal, Cleviprex |
| Alnylam Pharmaceuticals INC. | $266.42 | 2020-2025 | Onpattro |
| Actelion Pharmaceuticals US, INC. | $262.49 | 2019-2024 | Uptravi, Opsumit |
| Boston Scientific Corporation | $224.25 | 2020-2024 | Watchman Flx |
| Cardiovascular Systems INC. | $181.33 | 2019-2021 | |
| Astellas Pharma US INC | $143.35 | 2019-2022 | |
| Medtronic Vascular, INC. | $140.49 | 2019-2020 | |
| Amarin Pharma, INC. | $138.82 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $132.43 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $127.64 | 2023 | Gore Cardioform Septal Occluder |
| Scpharmaceuticals INC. | $117.18 | 2024-2025 | |
| Philips North America LLC | $113.08 | 2019 | |
| Impulse Dynamics (USA) INC. | $112.58 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $88.16 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $87.51 | 2021-2023 | Arcalyst |
| Davol INC. | $58.62 | 2023 | Tridyne Vascular Sealant |
| Cvrx, INC. | $56.07 | 2024-2025 | Barostim Neo System |
| Baxter Healthcare | $52.69 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Kowa Pharmaceuticals America, INC. | $50.99 | 2020-2021 | |
| Gilead Sciences, INC. | $49.18 | 2019 | |
| Atricure, INC. | $44.69 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $33.98 | 2024 | |
| Irhythm Technologies, INC. | $20.84 | 2023 | Zio Xt Patch |
| Vifor Pharma, INC. | $20.73 | 2019 | |
| Cardiva Medical, INC. | $19.19 | 2021 | |
| Veryan Medical Incorporated | $18.27 | 2024 | Biomimics 3d Vascular Stent System |
| Arbor Pharmaceuticals, INC. | $15.55 | 2019 | |
| Amryt Pharma Holdings LTD | $15.26 | 2020 | |
| Akcea Therapeutics, INC. | $14.68 | 2020 | |
| Cordis US Corp. | $14.16 | 2024 | Mynx Venous Vcd |
| Aegerion Pharmaceuticals, INC. | $12.95 | 2019 | |
| Nuwellis, INC. | $12.23 | 2019 | |
| Cook Medical LLC | $11.00 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Weirick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.